What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Blood pressure
Norman K. Hollenberg focuses on Internal medicine, Endocrinology, Angiotensin II, Renal blood flow and Renin–angiotensin system.
Norman K. Hollenberg works mostly in the field of Internal medicine, limiting it down to topics relating to Cardiology and, in certain cases, Pathology.
Endocrinology and Enzyme inhibitor are commonly linked in his work.
His Angiotensin II study incorporates themes from Nephropathy, Angiotensin-converting enzyme, Vascular smooth muscle and Captopril.
The study incorporates disciplines such as Vasoconstriction, Natriuresis, Renal physiology and Renal artery in addition to Renal blood flow.
His Renin–angiotensin system study combines topics from a wide range of disciplines, such as Salt intake and Pharmacology.
His most cited work include:
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy (955 citations)
- (–)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans (832 citations)
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. (453 citations)
What are the main themes of his work throughout his whole career to date?
Norman K. Hollenberg mainly investigates Internal medicine, Endocrinology, Renin–angiotensin system, Angiotensin II and Kidney.
The Internal medicine study which covers Cardiology that intersects with Surgery.
His Endocrinology study is mostly concerned with Aldosterone, Angiotensin-converting enzyme, Captopril, Renal circulation and Renal function.
His biological study spans a wide range of topics, including Diabetes mellitus, Blockade, Pharmacology and Enzyme inhibitor.
His Angiotensin II study frequently draws connections between adjacent fields such as ACE inhibitor.
His Renal blood flow research incorporates themes from Vasoconstriction and Renal artery.
He most often published in these fields:
- Internal medicine (73.08%)
- Endocrinology (55.45%)
- Renin–angiotensin system (34.62%)
What were the highlights of his more recent work (between 2002-2016)?
- Internal medicine (73.08%)
- Endocrinology (55.45%)
- Renin–angiotensin system (34.62%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Endocrinology, Renin–angiotensin system, Diabetes mellitus and Blood pressure.
The Internal medicine study combines topics in areas such as Nephropathy and Cardiology.
His research related to Renal blood flow, Angiotensin II, Plasma renin activity, Captopril and Diabetic nephropathy might be considered part of Endocrinology.
His Renin–angiotensin system study incorporates themes from Blockade, Angiotensin-converting enzyme, Pharmacology and Enzyme inhibitor.
His Diabetes mellitus research is multidisciplinary, relying on both Surgery, Endothelial dysfunction and Intensive care medicine.
His Kidney research focuses on Essential hypertension and how it relates to Aldosterone.
Between 2002 and 2016, his most popular works were:
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy (955 citations)
- (–)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans (832 citations)
- Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans (415 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Blood pressure
- Endocrinology
Internal medicine, Endocrinology, Blood pressure, Kidney and Renin–angiotensin system are his primary areas of study.
His Internal medicine research is multidisciplinary, incorporating elements of Diabetes mellitus, Urology and Cardiology.
Renal function, Angiotensin II, Plasma renin activity, Aliskiren and Nephropathy are among the areas of Endocrinology where the researcher is concentrating his efforts.
Norman K. Hollenberg combines subjects such as Hemodynamics, Cardiovascular health, Compliance and Pediatrics with his study of Blood pressure.
Kidney is a component of his Renal blood flow and Tubuloglomerular feedback studies.
His study focuses on the intersection of Renin–angiotensin system and fields such as Enzyme inhibitor with connections in the field of Renin inhibitor and Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
